BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29995652)

  • 21. In vivo cyclin E expression as a marker for early cervical neoplasia.
    Quade BJ; Park JJ; Crum CP; Sun D; Dutta A
    Mod Pathol; 1998 Dec; 11(12):1238-46. PubMed ID: 9872657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer.
    Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
    Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):223-31. PubMed ID: 17098349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. bcl-2 immunoreactivity, human papillomavirus DNA, and cervical intraepithelial neoplasia.
    Cooper K; Haffajee Z; Taylor L
    Mod Pathol; 1999 Jun; 12(6):612-7. PubMed ID: 10392638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
    Ovestad IT; Dalen I; Hansen E; Loge JL; Dybdahl BM; Dirdal MB; Moltu P; Berland JM
    Cancer Cytopathol; 2017 Apr; 125(4):283-291. PubMed ID: 27918650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of HPV-induced cervical (pre) neoplastic lesions: a tissue microarray (TMA) study.
    Arafa M; Boniver J; Delvenne P
    Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):422-32. PubMed ID: 18542030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. γH2Ax Expression as a Potential Biomarker Differentiating between Low and High Grade Cervical Squamous Intraepithelial Lesions (SIL) and High Risk HPV Related SIL.
    Leventakos K; Tsiodras S; Kelesidis T; Kefala M; Kottaridi C; Spathis A; Gouloumi AR; Pouliakis A; Pappas A; Sioulas V; Chrelias C; Karakitsos P; Panayiotides I
    PLoS One; 2017; 12(1):e0170626. PubMed ID: 28118377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of HOXB2 and HOXB13 proteins is associated with HPV infection and cervical cancer progression.
    Gonzalez-Herrera A; Salgado-Bernabe M; Velazquez-Velazquez C; Salcedo-Vargas M; Andrade-Manzano A; Avila-Moreno F; Pina-Sanchez P
    Asian Pac J Cancer Prev; 2015; 16(4):1349-53. PubMed ID: 25743797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endonuclease-resistant DNA: a novel histochemical marker for cervical intraepithelial neoplasia and cervical carcinoma.
    Castellanos MR; Davidov A; Punia V; Szerszen A; Maiman M; Lazzaro B; Ahern K; Banerjee P
    Int J Gynecol Pathol; 2012 Jan; 31(1):1-7. PubMed ID: 22123717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
    Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
    Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type.
    Swan DC; Tucker RA; Tortolero-Luna G; Mitchell MF; Wideroff L; Unger ER; Nisenbaum RA; Reeves WC; Icenogle JP
    J Clin Microbiol; 1999 Apr; 37(4):1030-4. PubMed ID: 10074522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-Risk HPV Testing in Primary Screening for Cervical Cancer in the Public Health System, São Paulo, Brazil.
    Levi JE; Martins TR; Longatto-Filho A; Cohen DD; Cury L; Fuza LM; Villa LL; Eluf-Neto J
    Cancer Prev Res (Phila); 2019 Aug; 12(8):539-546. PubMed ID: 31189569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p16INK4A immunoexpression and HPV in situ hybridization signal patterns: potential markers of high-grade cervical intraepithelial neoplasia.
    Kalof AN; Evans MF; Simmons-Arnold L; Beatty BG; Cooper K
    Am J Surg Pathol; 2005 May; 29(5):674-9. PubMed ID: 15832093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of human papillomaviruses (HPV-16,18) in cervical smears by in situ hybridization.
    Marin J; Ursic-Vrscaj M; Erzen M
    Isr J Med Sci; 1994; 30(5-6):448-50. PubMed ID: 8034501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokeratin7 and cytokeratin19 expression in high grade cervical intraepithelial neoplasm and squamous cell carcinoma and their possible association in cervical carcinogenesis.
    Lee H; Lee H; Cho YK
    Diagn Pathol; 2017 Feb; 12(1):18. PubMed ID: 28212672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of up-regulation of 67-kd laminin receptor to grade of cervical intraepithelial neoplasia and to high-risk HPV types and prognosis in cervical cancer.
    Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Syrjänen S; Favalli C; Syrjänen K;
    Acta Cytol; 2006; 50(1):6-15. PubMed ID: 16514834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analytical and clinical performances of a restriction fragment mass polymorphism assay for detection and genotyping of a wide spectrum of human papillomaviruses.
    Lee HP; Kim SO; Hwang TS; Bae JM; Kim SN; Kim JW; Hwang SY; Lee HS; Shin SK; Cho W; Hong SP
    J Med Virol; 2011 Mar; 83(3):471-82. PubMed ID: 21264868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Papillomavirus and the DNA Damage Response: Exploiting Host Repair Pathways for Viral Replication.
    Spriggs CC; Laimins LA
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28820495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of gene chip technology for high risk type human papillomavirus in cervical cancer screening].
    Li RZ; Shi JF; Zhou QZ; Wu RF; Li N; Wu LN; Zhou YQ; Wang Q; Liu ZH; Liu B; Qiao YL
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(5):307-11. PubMed ID: 16677522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
    JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.